9 tools
Calculates the AST/ALT ratio, a common clinical marker used to assess liver health by comparing serum levels of aspartate transaminase (AST) and alanine transaminase (ALT). Users input their respective numerical values into the dedicated fields, and the tool instantly computes the resulting De Ritis ratio. The platform presents this calculation within an interface designed with clinical-style insights, providing a quick reference point for understanding the relationship between these two enzymes. Healthcare professionals, students in medical fields, and individuals monitoring liver function utilize this calculator to interpret blood work results. It offers a systematic way to determine if the ratio falls into common patterns associated with specific types of hepatic stress or disease.
Calculates the prognosis of alcoholic hepatitis using Maddrey's discriminant function. This tool helps users estimate the likelihood of liver failure or death in patients with alcoholic hepatitis by analyzing blood test results. Doctors, nurses, and researchers involved in patient care for those with alcohol-related liver diseases would use this calculator to inform treatment decisions and provide better outcomes for patients.
Calculates the Aspartate Transaminase to Platelet Ratio Index (APRI) using user-provided laboratory values for aspartate transaminase (AST) and platelets. This ratio index provides a quick, non-invasive estimate of potential liver fibrosis or cirrhosis risk based on standard clinical measurements. The tool takes two key inputs, AST and platelet count, and processes them through the established formula to yield a single numerical score that helps gauge the severity of liver scarring. Medical professionals and clinicians utilize this resource to assess patient liver health efficiently during routine evaluations. By providing an immediate calculation of the APRI score, it assists in preliminary risk stratification when detailed imaging or biopsy results are not immediately available.
Calculates NAFLD fibrosis scores based on patient data, helping healthcare providers assess liver health in individuals with non-alcoholic fatty liver disease. This tool requires input of specific clinical parameters such as age, sex, body mass index, presence of diabetes, and levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). It then uses these inputs to estimate the stage of fibrosis in the liver. Doctors, hepatologists, and other medical professionals would use this tool to make informed decisions about treatment plans for patients with NAFLD. By providing a quantitative assessment of liver damage, it aids in diagnosing and monitoring progression of the disease, potentially improving patient outcomes through timely intervention.
Calculates liver function based on various clinical parameters in patients with cirrhosis, providing a score to assess prognosis and guide treatment decisions. Used by healthcare professionals to evaluate severity of liver cirrhosis and inform treatment strategies, particularly for those considering transplantation or management of complications.
Calculates the severity of Crohn's disease symptoms based on patients' responses to a series of questions about their digestive health, including frequency of bowel movements, stool consistency, presence of blood in stool, abdominal pain, and fever. Helps healthcare providers assess disease activity and tailor treatment plans accordingly. Doctors, nurses, and patients with Crohn's disease or those involved in their care would use this calculator to monitor the effectiveness of treatments and make informed decisions about managing the condition.
Calculates a patient's Model for End-Stage Liver Disease (MELD) score based on blood test results, aiding healthcare providers in prioritizing liver transplant candidates. Helps users quickly assess a patient's liver function and determine their position on the transplant waiting list by providing an objective MELD score.
Calculates the FIB-4 index, a non-invasive tool to assess liver fibrosis severity based on blood tests for aspartate transaminase (AST), platelet count, international normalized ratio (INR), and age. Users input these values into the calculator to get an estimated stage of liver fibrosis. Clinicians and patients interested in monitoring liver health or evaluating potential liver disease can use this tool. It aids in diagnosing advanced liver fibrosis without needing a biopsy, making it convenient for routine checkups or when further testing is necessary.
Calculates the 6-month survival rate in patients with alcoholic hepatitis treated with steroids using the Lille score formula. Users input demographic and clinical data, and the calculator provides an estimated survival probability based on the Lille scoring system. Physicians and hepatologists would use this tool to assess prognosis and guide treatment decisions for patients with alcoholic hepatitis undergoing steroid therapy. By providing a quantitative estimate of survival, it aids in making informed medical choices that can improve patient outcomes.
